<DOC>
	<DOCNO>NCT00264134</DOCNO>
	<brief_summary>Primary Objective : To determine maximum tolerate dose docetaxel give Irinotecan Carboplatin treatment inoperable lung cancer . Secondary Objective : To evaluate dose-related toxicity triple regimen patient inoperable lung cancer .</brief_summary>
	<brief_title>Docetaxel , Irinotecan , Carboplatin Extensive Stage Non-Small Cell Lung Cancer</brief_title>
	<detailed_description>A phase I/II dose escalate study determine maximum tolerate dose docetaxel give Irinotecan Carboplatin treatment inoperable lung cancer .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Camptothecin</mesh_term>
	<criteria>18 year older unresectable lung cancer measurable evaluable lesion Karnofsky PS great equal 60 % untreated CNS metastasis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Non-Small Cell Lung Cancer</keyword>
</DOC>